The use of continuous glucose monitoring has created new glucose metrics for both people with diabetes and healthcare professionals to incorporate into diabetes management. While A1C is an average, time-in-range (TIR) captures when glucose is in the target range (70 mg/dL-180 mg/dL for most individuals), as well as when glucose is above range and below range, providing critical information for treatment decisions as well as health behavior changes.
The key takeaways for this webinar include:
· Review the Consensus Guidelines for TIR measurement and goals
· Discuss why TIR is an intuitive CGM metric to guide treatment decisions
· Key principles when educating people with diabetes about TIR goals and opportunities to increase TIR
· Review a case study using TIR metrics to incorporate shared decision-making to modify the treatment plan